FASENRA (Benralizumab)


  • Fasenra is a medication for patients with eosinophilic¬†asthma and works by reducing the number of eosinophils in your blood.
  • Fasenra is administered as a shot under the skin. It is given once every four weeks for the first three doses, then once every eight weeks.
  • After you receive a dose of Fasenra, most infusion centers will monitor you for a period of time to make sure you do not have any reactions to the medication.
  • The most common side effects with Fasenra are:
  • Headache
  • Sore throat
  • Severe allergic reaction (Rare)